Complications of Immunosuppressive Therapy in Solid Organ Transplantation.
Explore this paper's citation graph
Summary
Availability of novel immunosuppressive drugs is the most important factor responsible for significant improvement in long-term graft survival rates after solid organ transplantation and cross-sectional imaging studies play a crucial role in the timely diagnosis and management of post-transplant infections and malignancies.
- Type
- article
- Published
- 2016-03-01
- Cited by
- 77
- References
- 74
- OpenAlex
- https://openalex.org/W26896226
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:32822865
Keywords
Psychology
References
- Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients.
- Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients
- Management of high-risk cutaneous squamous cell carcinoma.
- Immunosuppressive drugs after solid organ transplantation.
- Pneumocystis Pneumonia in Solid Organ Transplantation
- Cholangiocarcinoma complicating recurrent primary sclerosing cholangitis after liver transplantation
- Gastrointestinal mucormycosis: an evolving disease.
- Cumulative Incidence of Cancer After Solid Organ Transplantation
- Abdominal manifestations of posttransplantation lymphoproliferative disorder.
- Spectrum of Cancer Risk among U.S. Solid Organ Transplant Recipients: The Transplant Cancer Match Study
- Molecular and Immunologic Mechanisms of Cancer Pathogenesis in Solid Organ Transplant Recipients
- New concepts and best practices for management of pre- and post-transplantation cancer.
- Imaging Findings of Rhinocerebral Mucormycosis
- Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past
- HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients.
- Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS.
- Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
- Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies
- Predictors of Cancer Risk in the Long-Term Solid-Organ Transplant Recipient
- Immunosuppressive Drugs in Kidney Transplantation
Cited by
- Current Biochemical Monitoring and Risk Management of Immunosuppressive Therapy after Transplantation
- Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege
- Therapeutic Drug Monitoring of Tacrolimus in Saudi Kidney Transplant Patients
- Evaluation of Morbidity and Patient and Graft Survival in Kidney Transplant Recipients: Experience of Dokuz Eylul University Hospital
- Using the Logistic Regression to Predict Saudi’s Kidney Transplant Rejection Patients
- Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions
- Seroprevalence of a “new” bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients
- Regulatory T cells: tolerance induction in solid organ transplantation
- Endothelial colony forming cells (ECFCs) and biomaterials : a synergy for next-generation cardiovascular implants
- Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients
- Vascular regenerative surgery : promised land for tissue engineers?
- Strongyloides stercoralis; reporte de un caso en el post-trasplante renal
- Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells
- Blimp‐1 prolongs allograft survival without regimen via influencing T cell development in favor of regulatory T cells while suppressing Th1
- Exploring the Immunomodulatory Moonlighting Activities of Acute Phase Proteins for Tolerogenic Dendritic Cell Generation
- Longterm Survival and Cost‐Effectiveness of Immunosuppression Withdrawal After Liver Transplantation
- Immunosuppression following organ transplantation. Part 2: complications and their management.
- Correlation Between Stem and Progenitor Cells Number and Immune Response in Patients After Allogeneic Kidney Transplant
- Progress in Immunosuppressive Agents for Solid-Organ Transplantation.
- The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management
Related papers
No related papers recorded.